Prevention Studies

You can help us find a way to prevent type 1 diabetes.

If your screening results show you are in the early stages of T1D (Stage 1 or Stage 2), you may be able to participate in a prevention study. These studies are looking for ways to slow down or stop the disease.

In addition to the studies listed here, we are always planning future studies. If we don't currently offer a study that's right for you, you can opt in for monitoring by a TrialNet research team at the forefront of T1D research. That way, when a new study opens, you'll be among the first to know!

Current Prevention Studies

Abatacept

TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression. Learn more

Teplizumab

We are testing the drug teplizumab to see if it can delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production. Learn more